Jarrod Paul Holmes MD FACP
Breast Cancer, Hematologic Oncology
Hematology/Oncology Annadel Medical Group Vice Chair, Breast Cancer Leadership Program
Join to View Full Profile
3555 Round Barn CirSanta Rosa, CA 95403
Phone+1 707-528-1050
Fax+1 707-525-3874
Dr. Holmes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Jarrod Holmes, MD is an Oncologist based in Santa Rosa, CA, specializing in Breast Cancer and Hematologic Oncology. He completed his residency and internship in internal medicine at Naval Medical Center, San Diego, before pursuing a fellowship in hematology and medical oncology at the National Capital Consortium. Dr. Holmes graduated from Duke University School of Medicine in 2000. He is experienced in managing conditions such as thrombocytopenia, medical oncology, general/benign hematology, and leukopenia. His publications cover a range of topics in oncology and hematology and have been cited on multiple occasions in other professional writings.
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2004 - 2007
Naval Medical Center (San Diego)Residency, Internal Medicine, 2001 - 2003- Naval Medical Center (San Diego)Internship, Internal Medicine, 2000 - 2001
Duke University School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2008 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya
Human Vaccines & Immunotherapeutics. 2024-12-31 - Intravenous Cetirizine Premedication to Mitigate Infusion-Related Reactions.Timothy Tyler, Erik Stojanoff, Joan Cannon, Jessie J Um, Stacia Young
Journal of the Advanced Practitioner in Oncology. 2024-03-01 - 4 citationsIntravenous Cetirizine vs Intravenous Diphenhydramine for the Prevention of Hypersensitivity Infusion Reactions: Results of an Exploratory Phase 2 Study.Jarrod P. Holmes, Julio A. Peguero, R. Campbell Garland, Janine North, Stacia Young
Journal of Infusion Nursing. 2021-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
